Related Experiment Video
Updated: Jul 19, 2026
06:19
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Treatment of ulcerative colitis
1Center for the Study of Inflammatory Bowel Diseases, Gastrointestinal Unit, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts 02114, USA.
Current Opinion in Gastroenterology
|October 7, 2006
Summary
Current ulcerative colitis treatments focus on better local delivery of 5-aminosalicylate and corticosteroids, alongside new immunosuppressants like cyclosporine. Research expands knowledge on safety, especially during pregnancy, and explores controversial antibiotic roles.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Ulcerative colitis treatment advances focus on local drug delivery and novel immunosuppressants.
- 5-aminosalicylate and corticosteroid preparations offer incremental benefits, but dose-response limits are recognized.
- Safety data, particularly for use during pregnancy, is continuously updated.
Purpose of the Study:
- To review recent advancements in ulcerative colitis therapeutics.
- To highlight novel drug delivery systems and immunosuppressive agents.
- To discuss the evolving understanding of treatment safety and efficacy.
Main Methods:
- Literature review of recent studies on ulcerative colitis treatments.
- Analysis of new formulations and immunosuppressive agents.
- Examination of safety data, including use in pregnancy.
Main Results:
- Newer 5-aminosalicylate formulations show modest improvements in safety and tolerance.
- Novel corticosteroids offer safety benefits but limited therapeutic gains.
- Cyclosporine demonstrates efficacy in severe ulcerative colitis, with oral emulsion preparations showing promise.
- Tacrolimus has limited reported experience.
- The role of antibiotics remains controversial.
Conclusions:
- Treatment strategies for ulcerative colitis are evolving with improved drug delivery and new immunosuppressants.
- Cyclosporine is effective for severe disease, and safety profiles continue to be elucidated.
- Further research is needed to clarify the role of antibiotics and optimize treatment regimens.
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...